SONIA RODRIGUEZ: Open Payments
NPI 1265806038 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 127 payments from 13 companies in 2025. Trend: 2023 $2,214 · 2024 $2,107 · 2025 $2,503
Food & beverage: $2,503
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 35 | $671 |
| AstraZeneca Pharmaceuticals LP | 20 | $428 |
| Viatris Specialty LLC | 22 | $379 |
| GENZYME CORPORATION | 11 | $226 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $222 |
| Mallinckrodt Hospital Products Inc. | 9 | $173 |
| Amgen Inc. | 5 | $104 |
| Grifols USA, LLC | 3 | $89 |
| Insmed, Inc. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
Products named: NUCALA, YUPELRI, DUPIXENT, TRELEGY ELLIPTA, FASENRA, ACTHAR, BREZTRI, OFEV.
Industry payments across MS — which companies pay providers there.
